mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.09 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.09 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.09 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |